Drug intelligence / Profile preview

carnosine

Development stage
Phase 3
Lead developer
Fooding Group
Modality
Peptides, Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Carnosine is a naturally occurring dipeptide composed of beta-alanine and L-histidine. It is synthesized in the body and found at high concentrations in skeletal muscle as well as the brain and heart. Carnosine acts as an antioxidant by scavenging reactive oxygen species (ROS), chelating divalent metal ions, and inhibiting glycation processes that contribute to aging and tissue damage. It also has anti-inflammatory properties and can buffer pH in muscle tissue during intense exercise. Carnosine has been investigated for its potential benefits in conditions such as diabetes complications (e.g., nephropathy), neurodegenerative diseases (e.g., Alzheimer's disease), aging-related disorders, autism spectrum disorder symptoms, depression, heart failure, and Gulf War Illness[1][2][3][4][5]. Its mechanism of action includes antioxidant activity through ROS scavenging and metal ion chelation; antiglycation effects; anti-inflammatory actions; pH buffering; inhibition of lipid peroxidation; modulation of energy metabolism; protection against protein oxidation[4][5][6].

Other names
B-Alanyl-L-HistidineB-Alanyl HistidineBeta-alanyl-L-histidineCarnosinaL-CarnosineN-Acetyl-CarnosineN-Acetyl-L-Carnosine

Beyond the preview

Go deeper on carnosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carnosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call